MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
about
Targeting microRNAs as key modulators of tumor immune responseExosomes-mediate microRNAs transfer in breast cancer chemoresistance regulationmiRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cellsTumor suppressor role of miR-3622b-5p in ERBB2-positive cancer.MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cellsMicro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.New insights into the role of EMT in tumor immune escape.MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma CellsmiRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer.Exosomes as mediators of platinum resistance in ovarian cancer.MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.Targeting noncoding RNAs in disease.Involvement of microRNAs in HER2 signaling and trastuzumab treatment.MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.miRNAs: micro-managers of anticancer combination therapies.MicroRNA: A novel target of curcumin in cancer therapy.Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment.microRNAs Make the Call in Cancer Personalized Medicine.MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer.Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.The Different Mechanisms of Cancer Drug Resistance: A Brief Review.Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.Involvement of miR-451 in resistance to paclitaxel by regulating YWHAZ in breast cancer.The Pattern of microRNA Binding Site Distribution.Regulation of matrix stiffness on the epithelial-mesenchymal transition of breast cancer cells under hypoxia environment.PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.MiR-21 improves invasion and migration of drug-resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1.Functional miRNAs in breast cancer drug resistance.Single-Step Incubation Determination of miRNAs in Cancer Cells Using an Amperometric Biosensor Based on Competitive Hybridization onto Magnetic Beads.MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma.MiR-205 as predictive biomarker and adjuvant therapeutic tool in combination with trastuzumab.MiRNA-150-3p targets SP1 and suppresses the growth of glioma cells.HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancerMicroRNAs in regulation of triple-negative breast cancer progression
P2860
Q26746972-81F8F364-E6E0-4E61-88BB-4AA330706F62Q28066991-D8EA3B6A-B1A7-47EF-B032-73FFC341F00AQ31136911-A9C875B8-442F-4C45-9429-C54DDFDD8B3BQ33566944-D4E4D190-6D6B-4CDF-A533-3A9F55252927Q33618553-AA3D4CAE-F651-4486-8D1C-4AB7BA65FEA8Q33823801-EA1946EE-1EA4-4915-BBB3-ECF0CDDF7CD7Q33838622-633AED68-4CEB-4EAC-A072-CE5B855193F5Q33869781-16FA92A6-BF0F-43A2-B52C-6CFB485FB066Q36187533-18F752A5-E250-4E18-B346-DB2F766F28E6Q37412557-668FB7F5-D351-4915-9EF1-A13B3382503CQ37536942-E3BDA354-9D97-4749-A263-61ECE7AAF7B0Q37707018-EF77679A-9CAA-46FA-BB80-BB214CAAEB4AQ38706022-076893C9-7C3D-4F01-9608-A6E6B10CA296Q38752040-6F8BB91D-1268-4DDE-82AE-37E30D4EEE4EQ38979308-BE66A5AA-C9B3-4C51-A02E-B9911BC238B2Q39145491-D4252E8A-A6A3-4717-83BC-302B7CABCA19Q39285150-B9B7C63F-0C8A-49F8-98BC-DEA6FD7C6E91Q39375777-4881EF2C-3367-46CD-9176-8DF738E05B08Q39425138-CC355E13-62F9-4630-BCAB-2701D5943E33Q41390518-3A7A5A1E-01CB-49B8-89D0-1AA694B9B766Q42156325-ADFD37FA-2504-40AF-AA11-A10F589C3323Q42264081-C458B21D-9EEE-41B0-9B94-4B687D36C8B7Q42370727-0693495E-B8CA-4463-8D28-859308741C80Q42658274-FA9ECB6D-6DED-4C6E-B266-6BF1025D9971Q46036353-B234D260-2DF7-41DF-8F06-9E140871E5B3Q47109270-968FFD71-22C6-4E8D-BF31-667F7E484790Q47140557-5B0F7B1C-84AD-40C1-A558-C8D10C122EEDQ48314608-3A578B42-7825-44B4-B633-0D9024FBFC1DQ49357462-A4B15FEA-CA26-412E-AAB7-1911DD2639EDQ52657273-CE7836DE-9764-4D6F-9F28-1E501B527E05Q52660179-DB210C63-5FE7-41FA-8DFE-D047B4DE7517Q53694673-7621E517-3D7D-4FD3-984A-BF57CDA07025Q55000578-6FD7F0EC-851F-4EE8-9119-B792357F895AQ55025984-2E845A9B-2F07-484E-B005-6DB45B32059DQ55183040-FAD0102A-9F89-413C-B472-808E03A65675Q55374436-E5F76FFF-205B-4031-A560-49FE4CD26538Q55457308-82EEF9EF-A6F6-4A5F-91E3-F890573FEF1EQ57109545-EED490BA-1FDE-4280-9F86-4A375F1FBEE1Q57111303-0D0EFAF7-BC14-4D1A-B8B1-4F53B5409202
P2860
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@ast
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@en
type
label
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@ast
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@en
prefLabel
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@ast
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@en
P2093
P2860
P50
P356
P1433
P1476
MicroRNA-21 links epithelial-t ...... sitive breast cancer patients.
@en
P2093
Agnese Losurdo
Giovanna Masci
Giulia Bottai
José Pérez-Garcia
Libero Santarpia
P2860
P304
37269-37280
P356
10.18632/ONCOTARGET.5495
P407
P50
P577
2015-10-07T00:00:00Z